These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Simon EW; Blubaugh KM; Pippidis M Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820 [TBL] [Abstract][Full Text] [Related]
8. [Ocular pigmentation and phenothiazine derivatives]. Calluaud JL; Di Battista JC; Douenne JL; Lagoutte F Bull Soc Ophtalmol Fr; 1977; 77(7-8):661-4. PubMed ID: 26474 [No Abstract] [Full Text] [Related]
9. [Dangers of corticoid therapy in ophthalmology]. Himmat HW Rev Med Moyen Orient; 1967; 24(4):360-2. PubMed ID: 5269289 [No Abstract] [Full Text] [Related]
10. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices. Holden B; Gitlesen JP Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629 [TBL] [Abstract][Full Text] [Related]
12. The use of risperidone among individuals with mental retardation: clinically supported or not? Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072 [TBL] [Abstract][Full Text] [Related]
13. Psychoactive drug treatment in retarded populations. Psychopharmacol Bull; 1982 Jan; 18(1):50-66. PubMed ID: 6124020 [No Abstract] [Full Text] [Related]
14. Ocular changes associated with long term phenothiazine usage. Alexander TA; John JK; Thomas A; Verghese A Indian J Ophthalmol; 1985; 33(1):27-31. PubMed ID: 2867036 [No Abstract] [Full Text] [Related]
15. Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS). Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH Am J Ment Retard; 1997 Jan; 101(4):413-23. PubMed ID: 9017087 [TBL] [Abstract][Full Text] [Related]